Werbung
Werbung

LFST

LFST logo

LifeStance Health Group, Inc. Common Stock

7.39
USD
Gesponsert
+0.09
+1.30%
08. Jan., 16:00 UTC -5
Geschlossen
exchange

Nach-Markt

7.39

0.00
0.00%

LFST Ergebnisberichte

Positives Überraschungsverhältnis

LFST übertreffen die 10 der letzten 18Schätzungen.

56%

Nächster Bericht

Datum des nächsten Berichts
26. Feb. 2026
Estimate for Q4 25 (Revenue/ EPS)
$385.60M
/
$0.00
Implizierte Änderung von Q3 25 (Revenue/ EPS)
+5.99%
/
--
Implizierte Änderung von Q4 24 (Revenue/ EPS)
+18.47%
/
-100.00%

LifeStance Health Group, Inc. Common Stock earnings per share and revenue

On 06. Nov. 2025, LFST reported earnings of 0.00 USD per share (EPS) for Q3 25, beating the estimate of -0.01 USD, resulting in a 100.00% surprise. Revenue reached 363.81 million, compared to an expected 362.72 million, with a 0.30% difference. The market reacted with a +29.94% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 11 analysts forecast an EPS of 0.00 USD, with revenue projected to reach 385.60 million USD, implying an increase of 0.00% EPS, and increase of 5.99% in Revenue from the last quarter.
FAQ
For Q3 2025, LifeStance Health Group, Inc. Common Stock reported EPS of $0.00, beating estimates by 100%, and revenue of $363.81M, 0.3% above expectations.
The stock price moved up 29.94%, changed from $4.81 before the earnings release to $6.25 the day after.
The next earning report is scheduled for 26. Feb. 2026.
Based on 11 analysts, LifeStance Health Group, Inc. Common Stock is expected to report EPS of -- and revenue of $385.60M for Q4 2025.
Scheck FXEmpire's Earnings Calendar for today's list of reporting companies.
Werbung